Is Neuphoria Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: NEUP) stock is to Buy NEUP stock.
Out of 1 analyst, 0 (0%) are recommending NEUP as a Strong Buy, 1 (100%) are recommending NEUP as a Buy, 0 (0%) are recommending NEUP as a Hold, 0 (0%) are recommending NEUP as a Sell, and 0 (0%) are recommending NEUP as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NEUP price target, the average NEUP price target is $7.00, with the highest NEUP stock price forecast at $7.00 and the lowest NEUP stock price forecast at $7.00.
The Wall Street analyst predicted that Neuphoria Therapeutics's share price could reach $7.00 by Dec 5, 2026. The average Neuphoria Therapeutics stock price prediction forecasts a potential upside of 54.19% from the current NEUP share price of $4.54.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.